Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
sh Erste zugelassene Therapie für Myelofibrosepatienten. Im Focus Onkologie 17, 60 (2014). https://doi.org/10.1007/s15015-014-1236-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15015-014-1236-5